PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40125P00261Completion of FDA project ? development — Children'S Hospital Los Angeles

Children'S Hospital Los Angeles holds $-21,012 across 4 federal awards. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 18, 2026 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs
Awarding office
Children'S Hospital Los Angeles
Recipient
Sep 18, 2026
PoP end
$200K
Obligated
$200K
Potential
541990
NAICS
AJ12
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Children'S Hospital Los Angeles — $90

Contract facts

NONE
Contract number75F40125P00261
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentChildren'S Hospital Los Angeles
CAGE0RMZ8
UEIDVL1CMRMWRN9
NAICS541990

No full NAICS 541990 intel page yet. Browse NAICS intelligence

PSCAJ12
Place of performanceLOS ANGELES CA
Pricing typeTime And Materials
Extent competedCompeted Under SAP
PoP startSep 19, 2025
PoP end (current)Sep 18, 2026
Obligated$200K
Current value$200K
Potential value$200K

COMPLETION OF FDA PROJECT ? DEVELOPMENT OF A MODEL THAT INTEGRATES INFLAMMATION AND TISSUE INJURY TO PREDICT AND MITIGATE THE POST-ACUTE OF COVID19 is a federal NONE award for Fda Office Of Acq Grant Svcs held by Children'S Hospital Los Angeles. Estimated value $200K ($200K obligated). Current period of performance ends Sep 18, 2026. Last award drew 1 bidder. Place of performance: LOS ANGELES CA.

COMPLETION OF FDA PROJECT ? DEVELOPMENT OF A MODEL THAT INTEGRATES INFLAMMATION AND TISSUE INJURY TO PREDICT AND MITIGATE THE POST-ACUTE OF COVID19

Recompete timing

Public
Expiring in 28 days

Current PoP ends Sep 18, 2026 (28 days remaining). Agencies typically plan 12–18 months ahead — at 0.9 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Children'S Hospital Los Angeles$-21,012 obligated across 4 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)
Department of Veterans Affairs (VA)$40K · 100% of firm total

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Explore more pipelines →

Frequently asked questions

What is contract 75F40125P00261?

75F40125P00261 (Completion of FDA project ? development) is a Fda Office Of Acq Grant Svcs award with a potential value of $200K, currently held by Children'S Hospital Los Angeles. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40125P00261?

Fda Office Of Acq Grant Svcs awarded 75F40125P00261 to Children'S Hospital Los Angeles (potential $200K).

Who is the incumbent on 75F40125P00261?

Children'S Hospital Los Angeles is the incumbent with $-21,012 across 4 related awards in SCOUT’s public footprint. The current period of performance ends Sep 18, 2026.

When does Children'S Hospital Los Angeles’s 75F40125P00261 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 18, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40125P00261